Find a Clinical Trial
Filter
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Breast cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
PBCAR0191
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Armata Bacteriophage Study; disArm Study
Bacterial infection, Staphylococcus aureus
All genders
18-100
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
NRG-BN009
Brain cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
ON-TRK
Solid tumors
All genders
No minimum age
Recruiting now
Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center
Embrace
Urinary tract infections
All genders
60+
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
RECOVER VITAL
COVID-19
All genders
18+
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
S1925
Chronic lymphocytic leukemia (CLL), Lymphoma
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
COVID-19 Biorepository study
COVID-19
All genders
18+
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
Lyme Xenodiagnosis Phase II Study
Lyme disease
All genders
18+
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases